Level Chart

Level Chart

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Revenue is at a current level of 3.503B, up from 3.477B last quarter and up from 3.085B one year ago. This is a change of 0.75% from last quarter and 13.55% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 3.503B
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Average Growth Rate 21.44%
Value from Last Quarter 3.477B
Change from Last Quarter 0.75%
Value from 1 Year Ago 3.085B
Change from 1 Year Ago 13.55%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 3.503B
December 31, 2025 3.477B
September 30, 2025 3.343B
June 30, 2025 3.345B
March 31, 2025 3.085B
December 31, 2024 2.942B
September 30, 2024 2.731B
June 30, 2024 2.637B
March 31, 2024 2.445B
December 31, 2023 2.285B
September 30, 2023 2.185B
June 30, 2023 2.239B
March 31, 2023 2.11B
Date Value
December 31, 2022 2.005B
September 30, 2022 1.958B
June 30, 2022 1.996B
March 31, 2022 1.873B
December 31, 2021 1.884B
September 30, 2021 1.794B
June 30, 2021 1.883B
March 31, 2021 1.681B
December 31, 2020 1.014B
September 30, 2020 1.002B
June 30, 2020 834.00M
March 31, 2020 1.026B
December 31, 2019 1.151B

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Revenue is at a current level of 3.503B, up from 3.477B last quarter and up from 3.085B one year ago. This is a change of 0.75% from last quarter and 13.55% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 3.503B
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Average Growth Rate 21.44%
Value from Last Quarter 3.477B
Change from Last Quarter 0.75%
Value from 1 Year Ago 3.085B
Change from 1 Year Ago 13.55%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. 0.61%